Fondazione Don Carlo Gnocchi Onlus
dongnocchi.itTotal trials
183
Active
58
Phase 3
0
Total enrollment
332,844
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Gut microbiota | — | — | — | — | — | 1 | |
| Blood Sample | — | — | — | — | — | 1 |
Next readouts
- 2025-12-31
Top conditions
- Stroke40
- Multiple Sclerosis28
- Parkinson Disease14
- Rehabilitation10
- Stroke Sequelae4
- Chronic Obstructive Pulmonary Disease4
- Amputation3
- Autism Spectrum Disorder3
Frequently asked questions about Fondazione Don Carlo Gnocchi Onlus
- How many clinical trials does Fondazione Don Carlo Gnocchi Onlus have on ClinicalTrials.gov?
- Fondazione Don Carlo Gnocchi Onlus is listed as the lead sponsor on 183 clinical trials in ClinicalTrials.gov, 58 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Fondazione Don Carlo Gnocchi Onlus's trials are in Phase 3?
- 0 of Fondazione Don Carlo Gnocchi Onlus's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Fondazione Don Carlo Gnocchi Onlus focus on?
- Fondazione Don Carlo Gnocchi Onlus's most-studied conditions on ClinicalTrials.gov are Stroke, Multiple Sclerosis, Parkinson Disease, Rehabilitation, Stroke Sequelae.
- When are Fondazione Don Carlo Gnocchi Onlus's next clinical trial readouts?
- Fondazione Don Carlo Gnocchi Onlus has 1 upcoming primary-completion readout tracked here; the soonest is “Sarcopenia and Nutritional Status in a Rehabilitation Setting”, expected around 2025-12-31.